UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN)

Endocrinology, diabetes & metabolism, 2023-05, Vol.6 (3), p.e414-n/a

2023

Volltextzugriff (PDF)

Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT‐CGM system in Germany, Sweden and the United Kingdom (2018–2020)

Diabetic medicine, 2023-02, Vol.40 (2), p.e14946-n/a

2023

Volltextzugriff (PDF)

Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020

Diabetes technology & therapeutics, 2021-07, Vol.23 (7), p.508-511

2021

Volltextzugriff (PDF)

Is Continuous Glucose Monitoring Underappreciated in the UK?

European Endocrinology, 2017-08, Vol.13 (2), p.76-80

2017

Volltextzugriff (PDF)

Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems

Diabetes technology & therapeutics, 2019-03, Vol.21 (3), p.128-132

2019

Volltextzugriff (PDF)

648-P: Lag Times in a Seventh-Generation Continuous Glucose Monitoring System

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

Diabetes technology & therapeutics, 2022-04, Vol.24 (4), p.281-284

2022

Volltextzugriff (PDF)

622-P: Frequent Engagement with Retrospective Real-Time CGM Data Is Associated with Improved Glycemic Control

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

860-P: Benefits of Real-Time Sharing and Following of Continuous Glucose Monitoring Data from Youth

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

391-P: Hypoglycemia Reductions with the Dexcom G6 CGM System’s Predictive Alert

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

632-P: Glycemic Control in Diabetes Camp Attendees Remotely Monitored and Nonadjunctively Managed with CGM

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

266-OR: Rebound Hyperglycemia in Real-World Data and Its Mitigation with a CGM-Based Predictive Alert

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Regarding Singh et al, "Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes"

Journal of diabetes science and technology, 2024-09, Vol.18 (5), p.19322968241257003-1266

2024

Volltextzugriff (PDF)

Centralized Remote Monitoring of Continuous Glucose Monitoring Data at Diabetes Camp Mitigates Hypoglycemia

Journal of diabetes science and technology, 2021-07, Vol.15 (4), p.962-964

2021

Volltextzugriff (PDF)

81-LB: Continuous Glucose Monitoring Strategies and Devices at a Diabetes Camp

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

103-LB: Intergenerational Improvements of Continuous Glucose Monitoring Systems in Youth

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

2134-PUB: Clinical Pearl: Overtreatment of Hyperglycemia and Hypoglycemia Contributes to Excessive Glycemic Variability

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

388-P: Real-World Associations between Glucose Management Indicator and CGM-Derived Metrics of Hypoglycemia

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

65-OR: Remote Monitoring of CGM Data at Diabetes Camp Mitigates Hypoglycemia Day and Night

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Patients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

Journal of diabetes science and technology, 2021-07, Vol.15 (4), p.965-967

2021

Volltextzugriff (PDF)

The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range

Diabetes technology & therapeutics, 2018-08, Vol.20 (8), p.557

2018

Volltextzugriff (PDF)

Glucose Monitoring and Diabetes Management in the Time of Coronavirus Disease 2019

Journal of diabetes science and technology, 2020-07, Vol.14 (4), p.809-810

2020

Volltextzugriff (PDF)

The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in RangeData reported previously in Price, DA, et al. (2017). Glycemic impact of reduced frequency of blood glucose monitoring with continuous glucose monitoring use. Diabetes 66(S1):A239

Diabetes technology & therapeutics, 2018-08, Vol.20 (8), p.557-560

2018

Volltextzugriff (PDF)

Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes

Journal of diabetes science and technology, 2019-03, Vol.13 (2), p.254-258

2019

Volltextzugriff (PDF)

Continuous Glucose Monitors: Use of Waveform Versus Glycemic Values in the Improvements of Glucose Control, Quality of Life, and Fear of Hypoglycemia

Journal of diabetes science and technology, 2014-05, Vol.8 (3), p.488-493

2014

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(83)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN)

Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT‐CGM system in Germany, Sweden and the United Kingdom (2018–2020)

Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020

Is Continuous Glucose Monitoring Underappreciated in the UK?

Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems

648-P: Lag Times in a Seventh-Generation Continuous Glucose Monitoring System

With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

622-P: Frequent Engagement with Retrospective Real-Time CGM Data Is Associated with Improved Glycemic Control

860-P: Benefits of Real-Time Sharing and Following of Continuous Glucose Monitoring Data from Youth

391-P: Hypoglycemia Reductions with the Dexcom G6 CGM System’s Predictive Alert

632-P: Glycemic Control in Diabetes Camp Attendees Remotely Monitored and Nonadjunctively Managed with CGM

266-OR: Rebound Hyperglycemia in Real-World Data and Its Mitigation with a CGM-Based Predictive Alert

Regarding Singh et al, "Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes"

Centralized Remote Monitoring of Continuous Glucose Monitoring Data at Diabetes Camp Mitigates Hypoglycemia

81-LB: Continuous Glucose Monitoring Strategies and Devices at a Diabetes Camp

103-LB: Intergenerational Improvements of Continuous Glucose Monitoring Systems in Youth

2134-PUB: Clinical Pearl: Overtreatment of Hyperglycemia and Hypoglycemia Contributes to Excessive Glycemic Variability

388-P: Real-World Associations between Glucose Management Indicator and CGM-Derived Metrics of Hypoglycemia

65-OR: Remote Monitoring of CGM Data at Diabetes Camp Mitigates Hypoglycemia Day and Night

Patients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range

Glucose Monitoring and Diabetes Management in the Time of Coronavirus Disease 2019

Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes

Continuous Glucose Monitors: Use of Waveform Versus Glycemic Values in the Improvements of Glucose Control, Quality of Life, and Fear of Hypoglycemia

Suchergebnisse filtern